Product Name | Elexacaftor - API |
Product Code | DA-E027-01 |
Chemical name | Elexacaftor |
Synonyms | 5-(2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one Hydrochloride; N-(1,3-dimethyl-1H-pyrazole-4-sulfonyl)-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide; N-[(1,3-Dimethyl-1H-pyrazol-4-yl)sulfonyl]-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethyl-1-pyrrolidinyl]-3-pyridinecarboxamide; VX 445; (S)-N-((1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl)-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl)-2-(2,2,4-trimethylpyrrolidin-1-yl)nicotinamide; |
Impurity | NA |
CAS Number | 2216712-66-0 |
Alternate CAS # | NA |
Molecular form | C26H34F3N7O4S |
Appearance | White to Off-White Solid |
Melting Point | NA |
Mol. Weight | 597.66 |
Storage | 2-8°C Refrigerator |
Solubility | NA |
Stability | NA |
Category | impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals |
Boiling Point | NA |
Applications | Elexacaftor medication used in those that have cystic fibrosis with a f508del mutation. |
Dangerous Goods Info | NA |
References | NA |
Extra Notes | NA |
Documents (MSDS) | No Data Available |
Keywords | NA |